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eply
e are grateful to Drs. Heston and Wahl for their valuable
omments and suggestions to our study (1). They pose a question
egarding the use of a fixed threshold value for continuous data,
uch as a washout rate of iodine-123 metaiodobenzylguanidine
MIBG WR) for the prediction of prognosis, and propose an
lternative way to figure out and report such continuous variables.
lthough the method they propose is indeed intriguing, we think
here remain a few important problems to be discussed.
First, the clinical implication of the reference values that they
ropose would vary depending on the outcome to which the contin-
ous variable is related. For example, in the case where the outcome
s sudden cardiac death (SCD) as in our study, the patients with
ariables near the crossover point would be regarded as life-
hreatened patients, because they may belong to those with a high
isk of SCD, at a rate as high as 50%. Such patients might be
egarded as the good candidates for implantable cardioverter-
efibrillator therapy in most cases.
In dealing with the issues of life-threatening events like SCD,
e think we should put more emphasis on not overlooking the
atients at high risk than on not overlooking those at low risk. The
hreshold of MIBG WR 27% would be appropriate for this
urpose, because a negative predictive value as high as 92% could
e achieved with this threshold in our study patients (1).
Second, there may be a limitation on the method by Drs.
eston and Wahl, because their calculation is based on the
ssumption that the results of cardiac MIBG WR exactly follow a
ormal distribution. In fact, the specificity of abnormal MIBG
R (27%) for the prediction of SCD was 56% (1), which isifferent from (higher than) the specificity calculated by Drs.
eston and Wahl.
However, we agree with the suggestion by Drs. Heston and
ahl that there are some borderline cases that require difficult
ecision making, and that we should not rely only on the fixed
IBG WR value for the identification of the patients at high risk
or SCD. The only way to deal with these borderline cases might
e to take other clinical indexes that have been shown to be highly
redictive of SCD (i.e., left ventricular ejection fraction, electro-
ardiographic parameters such as T-wave alternans [2], or clinical
cores [3]) into account and judge the risk for SCD on a case by
ase basis.
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